Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Filipczak

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
International Journal of Pharmaceutics|December 11, 2024
Disulfiram-containing polymeric nanocapsules with anticancer activity for cancer treatmentNina Filipczak, Bharat Ashok Rajmalani, Janaina Artem Ataide, et al.
Drug Delivery and Translational Research|March 20, 2024
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice modelSatya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 12, 2019
Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistanceJiayi Pan, Livia P Mendes, Momei Yao, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 3, 2020
Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacyMuhammad Muzamil Khan, Asadullah Madni, Nina Filipczak, et al.
Research Square|January 3, 2024
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice modelSatya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, et al.
International Journal of Pharmaceutics|April 16, 2026
Exploring rifamycin cytotoxic potential through targeted liposomal formulationsJanaina Artem Ataide, Nina Filipczak, Satya Siva Kishan Yalamarty, et al.
Pharmaceutics|February 27, 2026
Calcium/Aluminum-Cored Asymmetric Bilayer Nanoparticles for Codelivery of Ziyuglycoside II and PD-L1 siRNA Exert Anti-Breast Tumor EffectsXiang Li, Xiangping Wu, Weiqiang Su, et al.
International Journal of Nanomedicine|June 3, 2022
Investigation of Eutectic Mixtures of Fatty Acids as a Novel Construct for Temperature-Responsive Drug DeliveryFarzana Parveen, Asadullah Madni, Vladimir P Torchilin, et al.
Cancers|April 13, 2023
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Molecular Pharmaceutics|April 3, 2020
Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNAJiayi Pan, Sara Aly Attia, Md Abdus Subhan, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|December 11, 2024
Disulfiram-containing polymeric nanocapsules with anticancer activity for cancer treatmentNina Filipczak, Bharat Ashok Rajmalani, Janaina Artem Ataide, et al.
Drug Delivery and Translational Research|March 20, 2024
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice modelSatya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 12, 2019
Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistanceJiayi Pan, Livia P Mendes, Momei Yao, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 3, 2020
Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacyMuhammad Muzamil Khan, Asadullah Madni, Nina Filipczak, et al.
Research Square|January 3, 2024
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice modelSatya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, et al.
International Journal of Pharmaceutics|April 16, 2026
Exploring rifamycin cytotoxic potential through targeted liposomal formulationsJanaina Artem Ataide, Nina Filipczak, Satya Siva Kishan Yalamarty, et al.
Pharmaceutics|February 27, 2026
Calcium/Aluminum-Cored Asymmetric Bilayer Nanoparticles for Codelivery of Ziyuglycoside II and PD-L1 siRNA Exert Anti-Breast Tumor EffectsXiang Li, Xiangping Wu, Weiqiang Su, et al.
International Journal of Nanomedicine|June 3, 2022
Investigation of Eutectic Mixtures of Fatty Acids as a Novel Construct for Temperature-Responsive Drug DeliveryFarzana Parveen, Asadullah Madni, Vladimir P Torchilin, et al.
Cancers|April 13, 2023
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Molecular Pharmaceutics|April 3, 2020
Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNAJiayi Pan, Sara Aly Attia, Md Abdus Subhan, et al.
Pageof 5